早期加用罗格列酮控制磺酰脲类单药治疗失败后高血糖的疗效：罗格列酮早期与磺酰脲类药物滴定（RESULT）研究。
Effectiveness of the early addition of rosiglitazone to control hyperglycemia after unsuccessful submaximal sulphonylurea monotherapy: the Rosiglitazone Early Versus SULphonylurea Titration (RESULT) Study.
机构信息
Datta Meghe Institute of Medical Sciences, Maharashtra, India.
出版信息
Phys Sportsmed. 2009 Apr;37(1):146-8. doi: 10.3810/psm.2009.04.1698.
PMID:20048503
Abstract
Practice Pearl: This study demonstrates the effectiveness of the early addition of rosiglitazone to control hyperglycemia after unsuccessful submaximal sulphonylurea monotherapy. Original Article: Rosenstock J, Goldstein BJ, Vinik AI, et al. RESULT Study Group. Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (> 60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study.
摘要
实践要点
本研究表明，对于磺酰脲类单药治疗失败后的高血糖患者，早期加用罗格列酮可有效控制血糖。原文：Rosenstock J, Goldstein BJ, Vinik AI, et al. RESULT 研究组。在年龄较大的 2 型糖尿病患者（>60 岁）中，早期加用罗格列酮与磺酰脲类药物滴定比较：罗格列酮早期与磺酰脲类药物滴定（RESULT）研究。
Zotero 插件